Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Aug;51(8):1108–1109. doi: 10.1136/jnnp.51.8.1108

Methylprednisolone in multiple sclerosis: a comparative dose study.

L Bindoff, P R Lyons, P K Newman, M Saunders
PMCID: PMC1033131  PMID: 3063777

Full text

PDF
1108

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbruzzese G., Gandolfo C., Loeb C. "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis. Ital J Neurol Sci. 1983 Jun;4(2):169–172. doi: 10.1007/BF02043900. [DOI] [PubMed] [Google Scholar]
  2. Barnes M. P., Bateman D. E., Cleland P. G., Dick D. J., Walls T. J., Newman P. K., Saunders M., Tilley P. J. Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):157–159. doi: 10.1136/jnnp.48.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buckley C., Kennard C., Swash M. Treatment of acute exacerbations of multiple sclerosis with intravenous methyl-prednisolone. J Neurol Neurosurg Psychiatry. 1982 Feb;45(2):179–180. doi: 10.1136/jnnp.45.2.179-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Compston D. A., Milligan N. M., Hughes P. J., Gibbs J., McBroom V., Morgan B. P., Campbell A. K. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results. J Neurol Neurosurg Psychiatry. 1987 May;50(5):517–522. doi: 10.1136/jnnp.50.5.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Durelli L., Cocito D., Riccio A., Barile C., Bergamasco B., Baggio G. F., Perla F., Delsedime M., Gusmaroli G., Bergamini L. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology. 1986 Feb;36(2):238–243. doi: 10.1212/wnl.36.2.238. [DOI] [PubMed] [Google Scholar]
  6. KUGELBERG E., COBB W. Repetitive discharges in human motor nerve fibers during the post-ischaemic state. J Neurol Neurosurg Psychiatry. 1951 May;14(2):88–94. doi: 10.1136/jnnp.14.2.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. KURTZKE J. F. FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS. Neurology. 1965 Jul;15:654–661. doi: 10.1212/wnl.15.7.654. [DOI] [PubMed] [Google Scholar]
  8. Lance J. W., Burke D., Pollard J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann Neurol. 1979 Jun;5(6):523–532. doi: 10.1002/ana.410050605. [DOI] [PubMed] [Google Scholar]
  9. Milligan N. M., Newcombe R., Compston D. A. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry. 1987 May;50(5):511–516. doi: 10.1136/jnnp.50.5.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Newman P. K., Saunders M., Tilley P. J. Methylprednisolone therapy in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1982 Oct;45(10):941–942. doi: 10.1136/jnnp.45.10.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Roth G. The origin of fasciculations. Ann Neurol. 1982 Dec;12(6):542–547. doi: 10.1002/ana.410120607. [DOI] [PubMed] [Google Scholar]
  12. Wallis W. E., Van Poznak A., Plum F. Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin. Arch Neurol. 1970 May;22(5):430–439. doi: 10.1001/archneur.1970.00480230048005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES